DAVITA INC (NYSE:DVA) released its second-quarter 2026 results after the close on Aug. 4, posting non-GAAP earnings of $4.02 per share on revenue of $3.55 billion. The stock nonetheless moved lower in after-market trading, falling roughly 7.5% as investors weighed a modest EPS beat against a top line that landed almost exactly on consensus.
Q2 results at a glance
For the quarter ended June 30, 2026, the company reported:
- Non-GAAP EPS: $4.02 versus analyst consensus of $3.92, a positive surprise of about 2.5%.
- Revenue: $3.55 billion versus consensus of $3.53 billion, a difference of less than 1%, which is effectively inline with expectations.
- Revenue growth from the prior-year period: 5.2%.
The EPS beat was clear but not by a wide margin, while the revenue figure did not provide an upside catalyst. In the press release, management said the quarter benefited from strong execution and continued progress on patient outcomes. CEO Javier Rodriguez also pointed to new innovations in kidney dialysis as a strategic focus for the rest of the year.
Market reaction
The after-hours move was the immediate focal point for investors. Extended trading indicated a decline of about 7.5%, and the stock had already lost ground in recent weeks.
- Last week: -4.8%
- Last two weeks: -3.9%
- Last month: -2.7%
That price action suggests the market was looking for a clearer beat or a more forceful revenue surprise. The company did not include formal outlook guidance in the release, so there is no updated full-year target to frame the result. With the report now out, the decline appears tied to positioning around the print and the reality that sales growth only matched expectations.
What to watch next
For the third quarter, analysts currently expect EPS of $3.97 and revenue of $3.57 billion. The full-year 2026 consensus sits at EPS of $14.97 and revenue of $14.29 billion. Those estimates will likely become the new reference points as investors assess whether the company can maintain its earnings trajectory in the second half.
Investors who want to review how quarterly results have trended over time can find more historical earnings information. For a view of what analysts expect in the coming quarters, the forecast page includes updated projections and estimates.
Disclaimer: This article is for informational and educational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Always conduct your own research and consider your risk tolerance before making investment decisions.
Read full article here »
View the Zacks #1 Rank List
DaVita (NYSE:DVA) Q2 2026: EPS Beats, Revenue In Line, Shares Fall 7.5%
DAVITA INC (NYSE:DVA) released its second-quarter 2026 results after the close on Aug. 4, posting non-GAAP earnings of $4.02 per share on revenue of $3.55 billion. The stock nonetheless moved lower in after-market trading, falling roughly 7.5% as investors weighed a modest EPS beat against a top line that landed almost exactly on consensus.
Q2 results at a glance
For the quarter ended June 30, 2026, the company reported:
The EPS beat was clear but not by a wide margin, while the revenue figure did not provide an upside catalyst. In the press release, management said the quarter benefited from strong execution and continued progress on patient outcomes. CEO Javier Rodriguez also pointed to new innovations in kidney dialysis as a strategic focus for the rest of the year.
Market reaction
The after-hours move was the immediate focal point for investors. Extended trading indicated a decline of about 7.5%, and the stock had already lost ground in recent weeks.
That price action suggests the market was looking for a clearer beat or a more forceful revenue surprise. The company did not include formal outlook guidance in the release, so there is no updated full-year target to frame the result. With the report now out, the decline appears tied to positioning around the print and the reality that sales growth only matched expectations.
What to watch next
For the third quarter, analysts currently expect EPS of $3.97 and revenue of $3.57 billion. The full-year 2026 consensus sits at EPS of $14.97 and revenue of $14.29 billion. Those estimates will likely become the new reference points as investors assess whether the company can maintain its earnings trajectory in the second half.
Investors who want to review how quarterly results have trended over time can find more historical earnings information. For a view of what analysts expect in the coming quarters, the forecast page includes updated projections and estimates.
Disclaimer: This article is for informational and educational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Always conduct your own research and consider your risk tolerance before making investment decisions.
Read full article here »